Category: Blog

Kevin P. Siu

May 21, 2026

New Health Canada Guidance on Biosimilars to Streamline Submissions

On May 19, 2026, Health Canada published the final version…
Read More
Hannah Goold

May 7, 2026

U.S. Supreme Court considers inducement liability for skinny-label generics

Last Wednesday, April 29, the Supreme Court of the United…
Read More
Kevin P. Siu

March 31, 2026

Announcing Canadian AI Case Tracker

It is no surprise that the proliferation of generative AI…
Read More
Kevin P. Siu

March 24, 2026

Did the Federal Court of Appeal rein in overbreadth invalidity?

The Federal Court of Appeal overturned a trial court finding…
Read More
Kevin P. Siu

March 20, 2026

Is password sharing circumvention? Blacklock’s Reporter copyright saga continues on appeal

The FCA overturned a lower court decision that declared sharing…
Read More
Hannah Goold

February 25, 2026

Federal Court strikes down proposed class action against generic pharmaceutical manufacturers for alleged industry-wide conspiracy

The Federal Court of Canada in Eaton v Teva Canada…
Read More
Kevin P. Siu

January 29, 2026

Federal Court sets threshold for filing new evidence on appeal of Trademark Opposition Board proceedings

The Federal Court has clarified when parties can file new…
Read More
Kevin P. Siu

January 13, 2026

AI Litigation in Canada: What to Watch for in 2026

Watch for these three developments in AI law in 2026:…
Read More